Our CEO David Llewelyn talked to Zoe Davies from Adlib Recruitment about how DJS Antibodies came to be, the exciting work we are doing and how we are always on…

We are excited to announce the completion of a £6M financing round to accelerate the development of our novel antibody therapeutics. 2021 is going to be a fantastic year working…

The 2020 Cherwell Business Awards had all the pomp and ceremony of years past, topped with a flavour that could only be fitting for a pandemic affected celebration. Instead of…

We speak to the Oxford Innovation team about how DJS started and what we’re working on.

Antibody therapeutics are becoming increasingly important for the treatment of many diseases, with the global market now worth more than $100bn. But discovering game-changing medicines is not for the fainthearted.…

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Morbi vitae dui et nunc ornare vulputate non fringilla massa.

BioStars is a flagship start-up accelerator dedicated to enabling bio-entrepreneurs to turn their scientific ideas into actual products. In 2017, DJS took home the People’s Choice Award.